scispace - formally typeset
Open AccessJournal ArticleDOI

Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis

TLDR
MR imaging-PDFF showed promise for assessment of hepatic steatosis grade in patients with NAFLD, and was significantly correlated with histologic steatotic grade.
Abstract
MR imaging with proton density fat fraction (PDFF) permitted high overall accuracy with moderate sensitivity and high specificity for classification of dichotomized steatosis grade, and these results support the conduct of further studies to help validate MR imaging–PDFF as a biomarker of hepatic steatosis in nonalcoholic fatty liver disease.

read more

Citations
More filters
Journal ArticleDOI

Accuracies of Chemical Shift In/Opposed Phase and Chemical Shift Encoded Magnetic Resonance Imaging to Detect Intratumoral Fat in Hepatocellular Carcinoma

TL;DR: In this paper, the diagnostic accuracy of chemical shift encoded fat fraction at three different flip angles (FAs) using quantitative CSE-MRI with in-/opposed phase (IOP) imaging to evaluate intratumoral fat in HCC was compared.
Journal ArticleDOI

Comparing mono-exponential, bi-exponential, and stretched-exponential diffusion-weighted MR imaging for stratifying non-alcoholic fatty liver disease in a rabbit model

TL;DR: Stretched-exponential DWI with higher fitting efficiency performed, as well as bi-exponian DWI, better than mono-exp exponential DWI in the stratification of NAFLD severity.
Journal ArticleDOI

Prospective study of change in liver function and fat in patients with colorectal liver metastases undergoing preoperative chemotherapy: protocol for the CLiFF Study.

TL;DR: A novel test of liver function is used, measured by the liver maximum capacity (LiMAx) test, and liver fat is measured by advanced MRI using both MR spectroscopy and the modified Dixon method, in up to 35 patients undergoing preoperative chemotherapy for CLM.
Journal ArticleDOI

3.0T 1H magnetic resonance spectroscopy for assessment of steatosis in patients with chronic hepatitis C

TL;DR: It is indicated that the (1)H MRS can be used as an indicator of steatosis in patients with chronic hepatitis C and is a noninvasive technique that can provide information on the effect of liver Steatosis on hepatic metabolic processes.
References
More filters
Journal ArticleDOI

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

TL;DR: There are no systems for grading necroinflammatory activity or for staging fibrosis as exist for various other forms of chronic liver disease and this study proposes a grading and staging system that reflects the unique histological features of nonalcoholic steatohepatitis.
Journal ArticleDOI

Sampling variability of liver fibrosis in chronic hepatitis C.

TL;DR: It is suggested that a length of at least 25 mm is necessary to evaluate fibrosis accurately with a semiquantitative score, because variability in the distribution of fibrosis within the liver is a major limitation when using more accurate methods such as automated image analysis.
Journal ArticleDOI

Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

TL;DR: Histologic lesions of NASH are unevenly distributed throughout the liver parenchyma; therefore, sampling error of liver biopsy can result in substantial misdiagnosis and staging inaccuracies.
Related Papers (5)